GP-Act III Acquisition Corp(GPAT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 46.35 | EPS (ttm) | 0.24 | Insider Own | 4.13% | Shs Outstand | 16.2M | Perf Week | 0.68% |
| Market Cap | 0.18B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 15.5M | Perf Month | -1.03% |
| Enterprise Value | 0.18B | PEG | - | EPS next Q | - | Inst Own | 62.92% | Short Float | 0.01% | Perf Quarter | 1.99% |
| Income | 0.01B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.03 | Perf Half Y | 2.27% |
| Sales | 0.00B | P/B | 2.18 | EPS next 5Y | - | ROA | 4.2% | Short Interest | 0.00M | Perf YTD | 3.32% |
| Book/sh | 5.07 | P/C | 17673.98 | EPS past 3/5Y | - | ROE | 4.56% | 52W High | -7.96% ($12.00) | Perf Year | 4.4% |
| Cash/sh | 0 | P/FCF | - | Sales past 3/5Y | - | ROIC | 10.3% | 52W Low | 4.59% ($10.56) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -33.36% | Gross Margin | - | Volatility(W/M) | - 0.59% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.13 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.05 | EPS Q/Q | -86.14% | Profit Margin | - | RSI (14) | 52.79 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.05 | Sales Q/Q | - | SMA20 | 0.26% ($11.02) | Beta | -0.01 | Target Price | - |
| Payout | - | Debt/Eq | 0.01 | Earnings | - | SMA50 | 1.19% ($10.92) | Rel Volume | 0 | Prev Close | $11.15 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 2.86% ($10.74) | Avg Volume(3M) | 0.07M | Price | $11.05 |
| IPO | 2024/7/1 | Option/Short | No/Yes | Trades | 5 | Volume | 8 | Change | -0.94% |
Company
GPAT is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💼 This is a Special Purpose Acquisition Company (SPAC) established with sponsorship from GP Investments, whose primary purpose is to go public through mergers with fundamentally proven, high-quality private companies. The company successfully listed through its IPO and is actively searching for promising U.S.-based target companies, leveraging GP Investments' extensive global network and deal execution capabilities built up over many years as a private equity firm.
Over the past 1 year, roughly in the middle
8% below its 1-year high.
GPAT has weak earning power
Tap to view numbers
The price looks about right
Trading at 46.4 times earnings.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 62.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
RNMN 0.00%
SPCZ 0.00%It ranks #4 in the industry
Based on market cap of $177M.
GPAT $177M PER 46.4
LION $3B PER -
BBCQ $2B PER -
CCXI $686M PER -
FAQ
What kind of company is GPAT?
GPAT belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of GPAT?
The market cap of GPAT is approximately $177M, ranking 4,211 within its sector.
What is the P/E ratio of GPAT?
GPAT has a P/E ratio of approximately 46.4x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for GPAT?
GPAT has recorded a 52-week high of $12.00 and a low of $10.56.
